201 results on '"Murphy, Sharon E."'
Search Results
2. Reduced nicotine in cigarettes in a marketplace with alternative nicotine systems: randomized clinical trial
3. Epigenome-wide association study of total nicotine equivalents in multiethnic current smokers from three prospective cohorts
4. Predicting nicotine metabolism across ancestries using genotypes
5. Association of Urinary Biomarkers of Tobacco Exposure with Lung Cancer Risk in African American and White Cigarette Smokers in the Southern Community Cohort Study.
6. Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness
7. Differences in exposure to toxic and/or carcinogenic volatile organic compounds between Black and White cigarette smokers
8. 2 ′ -Hydroxylation of Nicotine by Cytochrome P450 2A6 and Human Liver Microsomes: Formation of a Lung Carcinogen Precursor
9. Benzene Exposure, Assessed by Urinary trans,trans-Muconic Acid, in Urban Children with Elevated Blood Lead Levels
10. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching
11. Effects of MAO inhibition and a combination of minor alkaloids, β-carbolines, and acetaldehyde on nicotine self-administration in adult male rats
12. Evaluation of Toxicant and Carcinogen Metabolites in the Urine of E-Cigarette Users Versus Cigarette Smokers
13. The Impact of Reducing Nicotine Content on Adolescent Cigarette Smoking and Nicotine Exposure: Results From a Randomized Controlled Trial.
14. Association of internal smoking dose with blood DNA methylation in three racial/ethnic populations
15. Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai Cohort Study
16. Dose–Response Effects of Spectrum Research Cigarettes
17. Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial
18. Increased Levels of the Acrolein Metabolite 3‑Hydroxypropyl Mercapturic Acid in the Urine of e‑Cigarette Users.
19. Association of Urinary Biomarkers of Smoking-Related Toxicants with Lung Cancer Incidence in Smokers: The Multiethnic Cohort Study.
20. Quantitation of Ten Urinary Nicotine Metabolites, Including 4‑Hydroxy-4-(3-pyridyl) Butanoic Acid, a Product of Nicotine 2′-Oxidation, and CYP2A6 Activity in Japanese Americans, Native Hawaiians, and Whites.
21. Smoking reduction fails to improve clinical and biological markers of cardiac disease: A randomized controlled trial
22. Developing the science base for reducing tobacco harm
23. Smokeless tobacco topography and toxin exposure
24. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study
25. Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity
26. Associations Between Genetic Ancestries and Nicotine Metabolism Biomarkers in the Multiethnic Cohort Study
27. Randomized Trial of Reduced-Nicotine Standards for Cigarettes
28. Tobacco-Specific Nitrosamine Adducts: Studies in Laboratory Animals and Humans
29. Quantitation of DNA Adducts Resulting from Acrolein Exposure and Lipid Peroxidation in Oral Cells of Cigarette Smokers from Three Racial/Ethnic Groups with Differing Risks for Lung Cancer.
30. Cotinine and trans 3′-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism
31. Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups
32. Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study
33. Prenatal tobacco exposure and cotinine in newborn dried blood spots
34. Analysis of [3′,3′-d 2]-nicotine and [3′,3′-d 2]-cotinine by capillary liquid chromatography–electrospray tandem mass spectrometry
35. A Randomized Trial of Nicotine versus No-nicotine E-cigarettes Among African American Smokers: Changes in Smoking and Tobacco Biomarkers.
36. Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6
37. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation
38. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer
39. Multiethnic Prediction of Nicotine Biomarkers and Association With Nicotine Dependence.
40. Cross-sectional study of urinary biomarkers of environmental tobacco and e-cigarette exposure and asthma morbidity.
41. Evaluation of Carcinogen Exposure in People Who Used “Reduced Exposure” Tobacco Products
42. Effects of Reduced Cigarette Smoking on the Uptake of a Tobacco-Specific Lung Carcinogen
43. Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3
44. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke
45. Cigarette smoking enhances the metabolic activation of the polycyclic aromatic hydrocarbon phenanthrene in humans.
46. Detecting participant noncompliance across multiple time points by modeling a longitudinal biomarker.
47. Biochemistry of nicotine metabolism and its relevance to lung cancer.
48. Applying Tobacco, Environmental, and Dietary-Related Biomarkers to Understand Cancer Etiology and Evaluate Prevention Strategies.
49. Urinary Cyanoethyl Mercapturic Acid, a Biomarker of the Smoke Toxicant Acrylonitrile, Clearly Distinguishes Smokers From Nonsmokers.
50. UGT2B10 Genotype Influences Serum Cotinine Levels and Is a Primary Determinant of Higher Cotinine in African American Smokers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.